Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - SYNAVANT Inc. (NasdaqNM:SNVT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
3445 Peachtree Rd. NE., Suite 1400
Atlanta, GA 30326
Phone: (404) 841-4000
Fax: (404) 841-4115
Email: investorinfo@synavant.com
Employees (last reported count): 1,300
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Services
 ·Industry: Business Services
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 66%
·Over the last 6 months:
 · 2 insider buys; 15.0K shares (0.2% of insider shares)
·Institutional: 58% (170% of float)
(113 institutions)
·Net Inst. Buying: 251.0K shares (+2.81%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
SYNAVANT Inc. serves the pharmaceutical industry by developing and selling pharmaceutical relationship management solutions that support sales and marketing decision-making and program implementation. SYNAVANT offers sales and marketing effectiveness solutions that can be integrated with all client-critical databases to provide customer and business insights. SYNAVANT configures solutions for clients' sales and marketing teams, which include supporting desktop, laptop, handheld PC, and paper systems, linked to client companies' databases as required. Sales to the pharmaceutical industry accounted for substantially all of SYNAVANT's revenue in 2000. Through the Company's telecommunications programs, SYNAVANT provides a direct and responsive means of maintaining interactive communications with a target audience. This capability provides both in-bound and out-bound capabilities to healthcare professionals, sales representatives, and consumers.
More from Market Guide: Expanded Business Description

Financial Summary
SNVT serves the pharmaceutical industry by developing and selling pharmaceutical relationship management solutions that support sales and marketing decision making. For the six months ended 6/30/01, total revenues fell 3% to $90.8 million. Net loss increased 51% to $15.9 million. Revenues reflect the divestiture of EMRON and lower Interactive marketing. Net loss also reflects higher S/G/A expenses due to costs associated with being a public company.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Wayne Yetter, 55
Chairman, CEO
$1.1M
Craig Kussman, 42
Exec. VP, CFO, Chief Admin. Officer
370K
Jim Cain
Sr. VP of Global Marketingand Customer Devel.
--  
Robert Holmes
Sr. VP, Americas
--  
Ken Tyson
Sr. VP, International
--  
Dollar amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SNVTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$3.125
Recent Price$4.60 
52-Week High
on 5-Sep-2000
$10.125
Daily Volume (3-month avg)21.8K
Daily Volume (10-day avg)6,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-48.9%
52-Week Change
relative to S&P500
-31.4%
Share-Related Items
Market Capitalization$68.8M
Shares Outstanding15.0M
Float5.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.69 
Earnings (ttm)-$9.71 
Earnings (mrq)-$0.42 
Sales (ttm)$12.04 
Cash (mrq)$0.83 
Valuation Ratios
Price/Book (mrq)0.81 
Price/EarningsN/A 
Price/Sales (ttm)0.38 
Income Statements
Sales (ttm)$179.0M
EBITDA (ttm)-$14.2M
Income available to common (ttm)-$144.0M
Profitability
Profit Margin (ttm)-80.4%
Operating Margin (ttm)-82.3%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-83.55%
Return on Equity (ttm)-119.18%
Financial Strength
Current Ratio (mrq)1.58 
Debt/Equity (mrq)0 
Total Cash (mrq)$12.4M
Short Interest
As of 8-Aug-2001
Shares Short23.0K
Percent of Float0.5%
Shares Short
(Prior Month)
51.0K
Short Ratio1.09 
Daily Volume21.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.